Ault Milton C III

DirectorAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Dec 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2025Sell(S)2K$2.07$4K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-018631) within minutes of acceptance. Every field above traces to the original document. Verify it directly: